-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Segments
-
Pharmaceutical
-
Consumer Health
-
MedTech
-
Public Health & Government
-
Payer & Provider
Pharmaceutical (Global page)
Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Consumer Health
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
MedTech
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Public Health & Government
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Payer & Provider
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreHealthcare Provider Solutions
Solutions
-
Research & Development
-
Real World Evidence
-
Information Insights
-
Market Research
-
Strategy Consulting
-
Contract Sales & Medical Solutions
-
Patient Solutions
-
AI, Digital & Technology Solutions
Research & Development (Global page)
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Real World Evidence
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Information Insights
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Market Research
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Strategy Consulting
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORERelated Solutions
Contract Sales & Medical Solutions (Global page)
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
Patient Solutions (Global page)
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
AI, Digital & Technology Solutions
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREOur Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
IQVIA APAC Insight
"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue
Featured Event
"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreCareer Opportunities
Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search Jobs
Blog
Domestic Manufacturing in LMICs Part 3: Five Guiding Principles for Global Health Success
Jul 17, 2023
In our domestic manufacturing blog series, we have embarked on a journey to uncover the transformative potential of domestic manufacturing initiatives in healthcare systems. In Part 1: Lessons Learned with COVID-19, we delved into the lessons learned from the global pandemic, shedding light on the significance of equitable access, addressing disparities, and building resilience.
In Part 2: Building Supply Chain Resilience, we also explored how countries strategically approached their health system readiness and resilience through domestic manufacturing, forging partnerships and securing funding for scaling up regional and local vaccine production. As we conclude this series, we now turn our attention to key recommendations that will pave the way for the success of domestic manufacturing endeavors.
Developing domestic manufacturing is capital intensive. Therefore, careful assessments of country needs and capacity along with holistic systems planning, must be made to mitigate risk and guarantee not only a successful business launch but also long-term sustainability.
Five guiding principles
To aid this process, IQVIA recommends the following set of guiding principles. These principles encompass considerations in identifying the appropriate therapeutic areas and types of products for domestic manufacturing, gaps and risk assessment of national capacity, all while aligning the country's perspective with a broader global impact.
1. National Pride
Among many lessons learned from COVID-19, vaccine hesitancy is one of the major obstacles hampering effort to fight against the pandemic. Mistrust in vaccines developed in Western countries, for example, is one of the common factors behind vaccine hesitancy in African countries1. Therefore, having a locally made product may increase confidence and acceptance among the people.
2. Achieve Universal Health Coverage (UHC)
Producing essential medicines domestically improves local availability and potentially be more cost-effective in the long run. Reducing reliance on imports and the vulnerability to supply chain disruptions, strengthens the UHC efforts in ensuring consistent access to life-saving treatments.
3. Improve national security and pandemic preparedness
Moving the production closer to end-users, especially for products that are expected to be in high demand during the pandemic, may resolve issues around global supply disruption. Considering to locally produce active pharmaceutical ingredients (APIs) will partially offset dependency on major API producers such as China and India and improve resilience of a health system in the event of another global pandemic.
4. Increase national income through export
Domestic manufacturing should also be geared to be globally competitive to ensure its commercial success. Global market competitive assessment should be made to identify opportunities and to consider selection of products to be manufactured.
5. Meet existing and future burden of disease
Identifying and addressing unmet needs of the local population, for example, neglected diseases which may have been eradicated in most parts of the world, results in expensive products.
Building positive impact
As governments from lower-income economies seek funding to develop domestic manufacturing from global donors, it is an opportunity to align national interests to fill in the global unmet needs and gaps whether in products, therapeutic areas, potential future diseases, pharmaceutical platforms and technologies.
Key global health players may play the central role in initiating innovative partnerships between the domestic manufacturers, the local governments, and the global industry, forging mutual understanding and favorable terms, coordinating a network and improving information sharing for future pandemic preparedness. We outline below how inputs from domestic manufacturing builds up towards positive impact at the national and global level.
In conclusion, developing domestic manufacturing capabilities in healthcare systems holds tremendous promise for addressing critical challenges and fostering sustainable change. From bolstering national pride and achieving UHC to enhancing national security and increasing economic opportunities through exports, the benefits are multifold.
Moreover, by focusing on unmet local needs and forming innovative partnerships between domestic manufacturers, governments, and global industry players, there is potential to fill global gaps and improve health resilience against future global health threats.
By achieving the full potential of domestic manufacturing, we can make a lasting impact and ensure equitable access to essential life-saving treatments for all. For more information on improving population health outcomes, contact us.
References
1 https://blogs.worldbank.org/africacan/what-driving-covid-19-vaccine-hesitancy-sub-saharan-africa
IQVIA Public Health & Government
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.